These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8037609)

  • 1. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites.
    Ash SR
    Artif Organs; 1994 May; 18(5):355-62. PubMed ID: 8037609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy.
    Ash SR
    Adv Ren Replace Ther; 2002 Jan; 9(1):3-18. PubMed ID: 11927902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sorbent-based dialytic therapy with the BioLogic-DT on an experimental model of hepatic failure.
    Ash SR; Carr DJ; Blake DE; Rainier JB; Demetriou AA; Rozga J
    ASAIO J; 1993; 39(3):M675-80. PubMed ID: 8268623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT).
    Ash SR; Blake DE; Carr DJ; Carter C; Howard T; Makowka L
    Int J Artif Organs; 1992 Mar; 15(3):151-61. PubMed ID: 1521900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of sorbent suspension dialysis in cirrhotic patients with hepatic encephalopathy.
    Ash SR
    Am J Kidney Dis; 2001 Jul; 38(1):219-20. PubMed ID: 11431210
    [No Abstract]   [Full Text] [Related]  

  • 6. Push-pull sorbent based pheresis for treatment of acute hepatic failure: the BioLogic-detoxifier/plasma filter System.
    Ash SR; Blake DE; Carr DJ; Harker KD
    ASAIO J; 1998; 44(3):129-39. PubMed ID: 9617941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charcoal-based hemodiabsorption liver support for episodic type C hepatic encephalopathy.
    Hill K; Hu KQ; Cottrell A; Teichman S; Hillebrand DJ
    Am J Gastroenterol; 2003 Dec; 98(12):2763-70. PubMed ID: 14687830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy.
    Kramer L; Gendo A; Madl C; Ferrara I; Funk G; Schenk P; Sunder-Plassmann G; Hörl WH
    Am J Kidney Dis; 2000 Dec; 36(6):1193-200. PubMed ID: 11096044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Push-pull sorbent-based pheresis and hemodiabsorption in the treatment of hepatic failure: preliminary results of a clinical trial with the BioLogic-DTPF System.
    Ash SR; Steczko J; Knab WR; Blake DE; Carr DJ; Harker KD; Levy H
    Ther Apher; 2000 Jun; 4(3):218-28. PubMed ID: 10910024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new procedure for the removal of protein bound drugs and toxins.
    Stange J; Mitzner S; Ramlow W; Gliesche T; Hickstein H; Schmidt R
    ASAIO J; 1993; 39(3):M621-5. PubMed ID: 8268613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hemodiabsorption and sorbent-based pheresis on amino acid levels in hepatic failure.
    Steczko J; Bax KC; Ash SR
    Int J Artif Organs; 2000 Jun; 23(6):375-88. PubMed ID: 10919755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standardization of intensive therapy tactics for acute hepatic insufficiency in patients with liver cirrhosis after portosystem shunting].
    Ibadov RA; Babadzhanov AK; Irmatov SK; Gizatulina NR; Ibragimov SK; Ruziboev SA
    Khirurgiia (Mosk); 2018; (8):61-67. PubMed ID: 30113595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of extracorporeal ascites dialysis in combined hepatic and renal failure.
    Adler AJ; Feldman J; Friedman EA; Berlyne GM
    Nephron; 1982; 30(1):31-5. PubMed ID: 7088230
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of sorbent suspension dialysis on plasma amino acid levels in cirrhotic patients with refractory hepatic encephalopathy.
    Bauer E; Gendo A; Madl C; Garo F; Roth E; Kramer L
    Int J Artif Organs; 2002 Oct; 25(10):923-8. PubMed ID: 12456032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe tricyclic antidepressant overdose with extracorporeal sorbent detoxification.
    Ash SR; Levy H; Akmal M; Mankus RA; Sutton JM; Emery DR; Scanlon JC; Blake DE; Carr DJ
    Adv Ren Replace Ther; 2002 Jan; 9(1):31-41. PubMed ID: 11927905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cirrhosis--treating the ascites and encephalopathy.
    Hardison WG
    Med Times; 1979 May; 107(5):23-30. PubMed ID: 449639
    [No Abstract]   [Full Text] [Related]  

  • 17. Powdered sorbent liver dialysis and pheresis in treatment of hepatic failure.
    Ash SR
    Ther Apher; 2001 Oct; 5(5):404-16. PubMed ID: 11778927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention and therapy of complications of liver cirrhosis: ascites, encephalopathy and malnutrition].
    Köllinger M; Kullmann F; Holstege A; Schölmerich J
    Med Klin (Munich); 1996 Feb; 91(2):89-102. PubMed ID: 8850104
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodialysis alternative with ascites ultrafiltration for an end-stage renal failure patient associated with tense ascites secondary to decompensated liver cirrhosis.
    Hwang JC; Chen JA; Fung HY
    Am J Kidney Dis; 1996 Dec; 28(6):899-903. PubMed ID: 8957043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologic improvement of patients with hepatic failure and coma during sorbent suspension dialysis.
    Ash SR; Blake DE; Carr DJ; Carter C; Howard T; Makowka L
    ASAIO Trans; 1991; 37(3):M332-4. PubMed ID: 1751174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.